Indianapolis-based Eli Lilly and Co. is investing $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama. The effort is designed to expand U.S. production and create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results